149 related articles for article (PubMed ID: 3349494)
1. Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder.
Kakizoe T; Tobisu K; Takai K; Tanaka Y; Kishi K; Teshima S
Cancer Res; 1988 Apr; 48(8):2299-303. PubMed ID: 3349494
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of papillary and nodular carcinomas in the urinary bladder.
Kakizoe T; Matsumoto K; Tobisu K; Takai K; Teshima S; Kishi K
Jpn J Clin Oncol; 1987 Jun; 17(2):179-86. PubMed ID: 3613141
[TBL] [Abstract][Full Text] [Related]
3. Early lesions and natural progression of bladder carcinoma (minute bladder carcinoma).
Kishi K; Kakizoe T; Tobisu K; Tanaka Y; Niizuma M
Jpn J Clin Oncol; 1989 Mar; 19(1):3-13. PubMed ID: 2921815
[TBL] [Abstract][Full Text] [Related]
4. Transitional cell carcinoma of the upper urinary tract: analysis of morphology and distribution for surgical management.
Fujimoto H; Tobisu K; Mizutani T; Sakamoto M; Kakizoe T
Jpn J Clin Oncol; 1993 Oct; 23(5):303-8. PubMed ID: 8230755
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
7. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
[TBL] [Abstract][Full Text] [Related]
8. Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy.
Bianco FJ; Justa D; Grignon DJ; Sakr WA; Pontes JE; Wood DP
Urol Oncol; 2004; 22(4):290-4. PubMed ID: 15283885
[TBL] [Abstract][Full Text] [Related]
9. Two cases of bladder carcinoma with similar initial features that exhibited completely different clinical courses.
Kakizoe T; Ohtani M; Tobisu K; Matsumoto K; Teshima S; Kishi K
Jpn J Clin Oncol; 1986 Mar; 16(1):73-6. PubMed ID: 2939269
[TBL] [Abstract][Full Text] [Related]
10. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
11. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
12. [Total cystectomy for urinary bladder cancer: clinicopathological study of 95 cases].
Murase T; Takashi M; Aota Y; Shimoji T; Miyake K; Mitsuya H
Hinyokika Kiyo; 1985 Apr; 31(4):615-21. PubMed ID: 4036737
[TBL] [Abstract][Full Text] [Related]
13. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
14. [Spectrum of morphologic findings in cystectomy specimens].
Savvas V; Presse S; Kuntz RM
Verh Dtsch Ges Pathol; 1993; 77():266-70. PubMed ID: 7511295
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
[TBL] [Abstract][Full Text] [Related]
16. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.
Kamat AM; Dinney CP; Gee JR; Grossman HB; Siefker-Radtke AO; Tamboli P; Detry MA; Robinson TL; Pisters LL
Cancer; 2007 Jul; 110(1):62-7. PubMed ID: 17542024
[TBL] [Abstract][Full Text] [Related]
17. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
18. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I
Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
[TBL] [Abstract][Full Text] [Related]
19. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
[TBL] [Abstract][Full Text] [Related]
20. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?
Denzinger S; Fritsche HM; Otto W; Blana A; Wieland WF; Burger M
Eur Urol; 2008 Jan; 53(1):146-52. PubMed ID: 17624657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
